Patent ID: 11964057
Assignee: RJH BIOSCIENCES INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 24:
25. The method of claim 16, wherein the targeting ligand is selected from an antibody or fragment thereof, an aptamer from an oligonucleotide, a peptide, a protein, a polysaccharide, or a vitamin; the targeting ligand being specific for a cell surface molecule selected from JL1, CA19-9, CD2, CD3, CD5, CD19, CD20, CD33, CD34, CD38, CD44, CD52, CD74, CD96, CD99, CD117, CD135, CD166, CD184, CLL1, CXCR4, folate or folic acid, LFA-1, MMP-2, MMP-9, PTK7, sigma, transferrin, biotin, lectin, PD-1, or SMALF7.